Advanced microneedle technologies for sensing and delivery
Loading...
Author
Bichsel, C.
Petkus, B.
Boudoire, F.
Schildknecht, J.
Kurth, F.
Paoletti, S.
DOI
Abstract
Microneedles cause minimal pain yet penetrate the uppermost skin layer, making them attractive for minimally invasive drug delivery and biomarker tracking. Current bottlenecks for market adoption lie in microneedle sharpness for reliable application with minimal discomfort, minute sampling volumes, sensor miniaturization, and integration. CSEM develops microneedle technologies that overcome these challenges and proposes integrated solutions.
Publication Reference
CSEM Scientific and Technical Report 2025, p. 45–46
Year
2025